Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1089/oli.2006.16.2
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Name affiliation
  1. National Research Council of Canada. NRC Biotechnology Research Institute
FormatText, Article
Journal titleOligonucleotides
Volume16
Issue1
Pages214
Subjectbiotechnology; Cells; crossector; Hela Cells; pharmaceutical; Protein; Rna; therapy; Transforming Growth Factor beta
Publication date
LanguageEnglish
NRC number47756
NPARC number3539107
Export citationExport as RIS
Report a correctionReport a correction
Record identifierb8dacabf-51f8-4595-a4da-024d2f3845f8
Record created2009-03-01
Record modified2020-04-22
Date modified: